The concurrent activation of ferroptosis and RIPK3‐mediated necroptosis through Mn2+‐induced ROS and RIPK3 expression creates a potent synergistic effect that not only enhances tumor cell killing but also reorganizes the tumor immune microenvironment. The gene discussed is RIPK3; the disease is neoplasm.